Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C04AD03	PENTOXIFYLLINE SR	G	Pentoxifylline - 1160	400mg	Tablet, sustained release	1,478,227 L.L
M01AE01	PROFINAL	G	Ibuprofen - 400mg	400mg	Tablet, film coated	182,763 L.L
N03AX12	PMS-GABAPENTIN	G	Gabapentin - 400mg	400mg	Capsule	1,071,042 L.L
C10AA03	PRAVASTATINE ARROW	G	Pravastatin - 40mg	40mg	Tablet, breakable	526,786 L.L
N06BA09	PMS-ATOMOXETINE	G	Atomoxetine (HCl) - 40mg	40mg	Capsule	4,706,136 L.L
A02BC02	PANTO TAD	G	Pantoprazole (sodium) - 40mg	40mg	Tablet, gastroresistant	470,345 L.L
A02BC02	PANTOMAX	G	Pantoprazole (sodium sesquihydrate) - 40mg	40mg	Tablet, enteric coated	771,366 L.L
A02BC02	PANTOMAX	G	Pantoprazole (sodium sesquihydrate) - 40mg	40mg	Tablet, enteric coated	1,381,470 L.L
A02BC02	PANTOVER	G	Pantoprazole (sodium sesquihydrate) - 40mg	40mg	Tablet, enteric coated	739,113 L.L
A02BC02	PANTONIX-JULPHAR	G	Pantoprazole - 40mg	40mg	Injectable powder for solution	260,705 L.L
A02BC02	PANTOPRAZOL SALA	G	Pantoprazole (sodium) - 40mg	40mg	Injectable powder for solution	503,941 L.L
A02BC05	PRIMAZOL 40	G	Esomeprazole (magnesium dihydrate) - 40mg	40mg	Capsule, gastro-resistant	639,925 L.L
A02BC05	PROTREX	G	Esomeprazole - 40mg	40mg	Capsule	646,324 L.L
A02BC05	PUMPINOX	G	Esomeprazole - 40mg	40mg	Tablet, enteric coated	649,076 L.L
C07AA05	PROBETOL	G	Propranolol HCl - 40mg	40mg	Tablet	159,981 L.L
L01FD02	PERJETA 420MG	BioTech	Pertuzumab - 420mg/14ml	420mg/14ml	Injectable concentrate for solution	L.L
L01FD02	PERTUVIA	BioTech	Pertuzumab - 420mg/14ml	420mg/14ml	Injectable concentrate for solution	L.L
L01FD02	PECTUNA	BioTech	Pertuzumab - 420mg/14ml	420mg/14ml	Injectable concentrate for solution	132,032,880 L.L
L01FD02	PERJETA 420MG	BioTech	Pertuzumab - 420mg/14ml	420mg/14ml	Injectable concentrate for solution	220,054,714 L.L
L01FD02	PERTUVIA	BioTech	Pertuzumab - 420mg/14ml	420mg/14ml	Injectable concentrate for solution	147,592,404 L.L
J05AX18	PREVYMIS	B	Letermovir - 480mg	480mg	Tablet, film coated	961,233,292 L.L
A07EC02	PENTASA	B	Mesalazine - 4g	4g	Granules, prolonged release	8,513,063 L.L
N05AX08	PMS-RISPERIDONE	G	Risperidone - 4mg	4mg	Tablet	1,276,650 L.L
C10AA08	PIVAL	G	Pitavastatin - 4mg	4mg	Tablet	1,265,772 L.L
R06AX02	PERIACTIN	B	Cyproheptadine HCl - 4mg	4mg	Tablet	255,970 L.L
C01CA06	PHENYLEPHRINE AGUETTANT	G	Phenylephrine - 500mcg/10ml	500mcg/10ml	Injectable solution	11,464,796 L.L
C01EA01	PROSTIN VR	B	Alprostadil - 500mcg/ml	500mcg/ml	Injectable concentrated solution	19,894,577 L.L
N02BE51	PANADOL NIGHT	B	Paracetamol - 500mg, Diphenhydramine HCl - 25mg	500mg	Caplet	315,803 L.L
M01AE02	PROXEN 500	B	Naproxen - 500mg	500mg	Tablet, film coated	915,157 L.L
J01XD02	PROTOGYN	G	Tinidazole - 500mg	500mg	Tablet, film coated	217,702 L.L

...